FDA grants orphan drug designation to Savara Pharma inhaled antibiotic therapy
The antibiotic, AeroVanc, is a proprietary inhaled dry powder form of vancomycin in a capsule-based device designed for convenient self-administration. In Phase I studies, AeroVanc was well tolerated